Hati Kobusingye
Overview
Explore the profile of Hati Kobusingye including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
86
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stefanski H, Kuxhausen M, Bo-Subait S, Kobusingye H, Mattila D, Schenfeld J, et al.
Blood Adv
. 2024 Apr;
8(15):4196-4206.
PMID: 38687368
Allogeneic hematopoietic cell transplantation is a life-saving procedure used to treat a variety of devastating diseases. It requires hematopoietic stem cells collected via filgrastim-mobilized peripheral blood stem cells (PBSCs) or...
2.
Seftel M, Chitphakdithai P, Miller J, Kobusingye H, Logan B, Linenberger M, et al.
Transplant Cell Ther
. 2021 Apr;
27(4):352.e1-352.e5.
PMID: 33836890
The incidence and risk factors for severe adverse events (SAEs) in related donors (RD) of hematopoietic cell transplants is unknown. The Related Donor Safe study is a prospective observational cohort...
3.
Health-Related Quality-of-Life Comparison of Adult Related and Unrelated HSC Donors: An RDSafe Study
Switzer G, Bruce J, Kiefer D, Kobusingye H, Abebe K, Drexler R, et al.
Biol Blood Marrow Transplant
. 2020 Aug;
26(12):2365-2371.
PMID: 32829080
Multiple investigations have documented the health-related quality-of-life (HRQoL) and donation-related experiences of unrelated donors (URDs), but similar investigations of the related donor (RD) experience have been less common. The central...
4.
Chen Y, Le-Rademacher J, Brazauskas R, Kiefer D, Hamadani M, Dipersio J, et al.
Blood Adv
. 2019 Mar;
3(6):875-883.
PMID: 30890544
Plerixafor, a direct antagonist of CXCR4/stromal-derived factor 1, can safely and rapidly mobilize allografts without the use of granulocyte colony-stimulating factor (G-CSF). We conducted a phase 2, multicenter, prospective study...
5.
Pulsipher M, Logan B, Kiefer D, Chitphakdithai P, Riches M, Rizzo J, et al.
Biol Blood Marrow Transplant
. 2019 Jan;
25(5):955-964.
PMID: 30605731
Although donation of bone marrow (BM) or peripheral blood stem cells (PBSCs) from children to family members undergoing allogeneic transplantation are well-established procedures, studies detailing levels of pain, symptoms, and...
6.
Pulsipher M, Logan B, Chitphakdithai P, Kiefer D, Riches M, Rizzo J, et al.
Biol Blood Marrow Transplant
. 2018 Nov;
25(4):699-711.
PMID: 30423480
The development of reduced-intensity approaches for allogeneic hematopoietic cell transplantation has resulted in growing numbers of older related donors (RDs) of peripheral blood stem cells (PBSCs). The effects of age...
7.
Pulsipher M, Logan B, Kiefer D, Chitphakdithai P, Riches M, Rizzo J, et al.
Haematologica
. 2018 Nov;
104(4):844-854.
PMID: 30381298
Unlike unrelated donor registries, transplant centers lack uniform approaches to related donor assessment and deferral. To test whether related donors are at increased risk for donation-related toxicities, we conducted a...
8.
Weisdorf D, Cooley S, Wang T, Trachtenberg E, Haagenson M, Vierra-Green C, et al.
Biol Blood Marrow Transplant
. 2018 Aug;
25(1):e28-e32.
PMID: 30149149
We previously reported that acute myelogenous leukemia (AML) transplants using killer cell immunoglobulin-type receptor (KIR) B haplotype better or best (≥2 B activating gene loci ± Cen B/B) unrelated donors...
9.
Switzer G, Bruce J, Kiefer D, Kobusingye H, Drexler R, Besser R, et al.
Biol Blood Marrow Transplant
. 2016 Oct;
23(1):165-171.
PMID: 27751935
The increasing number of older adults with blood-related disorders and the introduction of reduced-intensity conditioning regimens has led to increases in hematopoietic stem cell (HSC) transplantation among older adults and...
10.
Switzer G, Bruce J, Kiefer D, Kobusingye H, Drexler R, Besser R, et al.
J Pediatr
. 2016 Aug;
178:164-170.e1.
PMID: 27522440
Objectives: To examine health-related quality of life (HRQoL) among sibling pediatric hematopoietic stem cell donors from predonation through 1 year postdonation, to compare donor-reported HRQoL scores with proxy-reports by parents/guardians...